v3.26.1
COMMITMENTS AND CONTINGENCIES (Detail Textuals) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Commitments [Line Items]    
Total expenses $ 11,529 $ 9,594
Patent Transfer Agreement [Member]    
Commitments [Line Items]    
Percentage of net revenues 3.00%  
D.N.A Biomedical Solutions Ltd [Member] | Joint Venture Agreement [Member]    
Commitments [Line Items]    
Amount of investment in entity $ 600  
D. N. A Biomedical Solutions Ltd And Oramed Ltd [Member] | Joint Venture Agreement [Member]    
Commitments [Line Items]    
Percentage of ownership of entity acquired 50.00%  
Government of Israel [Member]    
Commitments [Line Items]    
Percentage sales of products developed from projects in first three years, from commencement of revenues 3.00%  
Percentage sales of products developed from projects subsequent three years 4.00%  
Percentage sales of products developed from projects commencing the seventh year up to 100% of amount of grant received 5.00%  
Total royalty amount payable $ 460  
Percentage of each payment received from Amgen 5.38%  
Royalty amount paid $ 96